Your browser doesn't support javascript.
loading
One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatment.
Tseng, Tai-Chung; Choi, Jonggi; Nguyen, Mindie H; Peng, Cheng-Yuan; Siakavellas, Spyros; Papatheodoridis, George; Wang, Chia-Chi; Lim, Young-Suk; Lai, Hsueh-Chou; Trinh, Huy N; Wong, Christopher; Wong, Clifford; Zhang, Jian; Li, Jiayi; Kao, Jia-Horng.
Afiliação
  • Tseng TC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, 1 Chang-Te St, Taipei, 10002, Taiwan.
  • Choi J; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
  • Nguyen MH; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
  • Peng CY; Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Siakavellas S; Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA, USA.
  • Papatheodoridis G; School of Medicine, China Medical University, Taizhong, Taiwan.
  • Wang CC; Division of Hepatogastroenterology, Department of Internal Medicine, China Medical University Hospital, Taizhong, Taiwan.
  • Lim YS; Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens "Laiko", Athens, Greece.
  • Lai HC; Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens "Laiko", Athens, Greece.
  • Trinh HN; Division of Gastroenterology, Department of Internal Medicine, Taipei Tzuchi Hospital, The Buddhist Tzuchi Medical Foundation, New Taipei City, Taiwan.
  • Wong C; School of Medicine, Tzu Chi University, Hualien, Taiwan.
  • Wong C; Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Zhang J; School of Medicine, China Medical University, Taizhong, Taiwan.
  • Li J; San Jose Gastroenterology, San Jose, CA, USA.
  • Kao JH; Wong Clinics, San Francisco, CA, USA.
Hepatol Int ; 15(1): 105-113, 2021 Feb.
Article em En | MEDLINE | ID: mdl-33547557

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Hepatite B Crônica / Cirrose Hepática / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Hepatol Int Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Taiwan

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Hepatite B Crônica / Cirrose Hepática / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Hepatol Int Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Taiwan